Prodromal Parkinson's disease: hype or hope for disease-modification trials?

The ultimate goal in Parkinson's disease (PD) research remains the identification of treatments that are capable of slowing or even halting the progression of the disease. The failure of numerous past disease-modification trials in PD has been attributed to a variety of factors related not only...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahlknecht, Philipp, Marini, Kathrin, Werkmann, Mario, Poewe, Werner, Seppi, Klaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859908/
https://www.ncbi.nlm.nih.gov/pubmed/35184752
http://dx.doi.org/10.1186/s40035-022-00286-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859908/
https://www.ncbi.nlm.nih.gov/pubmed/35184752
http://dx.doi.org/10.1186/s40035-022-00286-1

Ejemplares similares